XML 31 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Note 2 - Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

Exercise price per warrant

 $33.00 

Conversion rate - common shares per warrant

  1.50 

Closing price of common stock

 $23.72 

Volatility

  75%

Risk-free interest rate

  5.40%

Expected life of option (in years)

  0.3 

Dividend yield

 

zero

 
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Three months ended March 31,

 
  

2025

  

2024

 

Operating expenses

        

Research and development

 $(13,666) $(16,233)

General and administrative

  (10,920)  (3,701)

Other segment items(a)

  1,183   44,977 

Net income (loss)

 $(23,403) $25,043 
    
  

March 31, 2025

  

December 31, 2024

 

Cash and cash equivalents

 $117,328  $128,574 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Three months ended

 
  

March 31,

 
  

2025

  

2024

 

Numerator, basic:

        

Net income (loss)

 $(23,403) $25,043 

Denominator, basic:

        

Weighted average common shares outstanding

  48,262   43,001 

Net income (loss) per share, basic

 $(0.48) $0.58 
         

Numerator, diluted:

        

Net income (loss)

 $(23,403) $25,043 

Adjustment for change in fair value of warrant liabilities

     (43,792)

Adjusted numerator, diluted

 $(23,403) $(18,749)

Denominator, diluted:

        

Weighted average common shares outstanding

  48,262   43,001 

Dilutive effect of common stock warrants

     1,101 

Weighted average dilutive common shares

  48,262   44,102 

Net loss per share, diluted

 $(0.48) $(0.43)
         

Dilutive common stock options excluded from net loss per share, diluted

  3,751   2,664 

Dilutive Performance Awards excluded from net loss per share, diluted

  7   7